Profile
BBNX LH NVST CON KDLY NEUE
Company Name Beta Bionics, Inc. Laboratory Corporation of America Holdings Envista Holdings Corp Concentra Group Holdings Parent, Inc. Kindly MD, Inc. NeueHealth, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Equipment & Services Medical - Equipment & Services Medical - Equipment & Services Medical - Equipment & Services Medical - Equipment & Services Medical - Equipment & Services
Market Cap $549.32M $21.68B $3.46B $2.55B $72.69M $61.33M
Employees 0.35K 60.90K 12.30K 8.76K 0.02K 0.99K
CEO Sean T. Saint PE Adam H. Schechter Paul A. Keel William Keith Newton Timothy Pickett George Lawrence Mikan III
Ratings
BBNX LH NVST CON KDLY NEUE
Quant Rating Score 2 3 2 3 1 1
Quant Rating Sell Neutral Sell Neutral Strong Sell Strong Sell
Trading
BBNX LH NVST CON KDLY NEUE
Last Close $12.67 $249.62 $20.2 $19.9 $12.23 $6.83
High 52 $23.52 $264.27 $22.33 $24.45 $24.94 $7.54
Low 52 $9.71 $206.17 $14.78 $19.47 $0.83 $3.82
Price vs. 52 Week High -46.13 % -5.54 % -9.54 % -18.61 % -50.96 % -9.42 %
Price vs. 52 Week Low 30.48 % 21.07 % 36.67 % 2.21 % 1373.49 % 78.8 %
Total Return
BBNX LH NVST CON KDLY NEUE
1 Month Return -34.99 % -4.59 % 7.05 % -8.4 % -27.76 % -0.29 %
3 Month Return 16.13 % 12.72 % 30.66 % -1.92 % 611.05 % 11.6 %
6 Month Return 0 % 7.59 % 8.72 % 0.86 % 755.24 % -6.82 %
9 Month Return 0 % 15.36 % 11.42 % -0.95 % 779.86 % 16.75 %
YTD Return 0 % 8.85 % 4.72 % 0.61 % 886.29 % -7.95 %
1 Year Return 0 % 21.07 % 25.94 % 0 % 410.65 % 33.14 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BBNX LH NVST CON KDLY NEUE
Dividend Yield Percentage (TTM) - 1.11 % - 0.94 % - -
Dividend Paid and Capex Coverage Ration (TTM) -35.69 % 2.25 % 10.33 % 0.15 % -9.54 % -29 %
Dividend Per Share (TTM) - 2.88 % - 0.19 % - -
Payout Ratio (TTM) - 33.2 % - 987.07 % - -
Growth
BBNX LH NVST CON KDLY NEUE
Asset Growth 35.99 % -18.99 % 8.04 % 234.61 %
Gross Profit Growth 468.93 % -5.36 % 20.16 % 1763.37 %
Revenue Growth 442.93 % -2.18 % 3.38 % -27.83 %
Revenue 3 Year 28465.39 % -6.32 % 8.4 % 20.29 %
Revenue 5 Year 28465.39 % -27.83 % 8.4 % 20.29 %
Revenue 10 Year 28465.39 % -19.08 % 8.4 % 20.29 %
EBIT Growth -26.22 % -12315.29 % 5.01 % -106.47 %
Net Income Growth -24.17 % -1016.37 % -7.45 % -123.66 %
Net Income 3 Yeari Growth Per Share 33.6 % -497.4 % -21.22 % -2783.05 %
Net Income 5 Yeari Growth Per Share 33.6 % -506.59 % -21.22 % -2783.05 %
Net Income 10 Yeari Growth Per Share 33.6 % -469.22 % -21.22 % -2783.05 %
Operating Income Growth -26.22 % -3395.87 % 6.05 % -106.56 %
Operating Cash Flow Growth (CFG) -48.78 % 22.05 % 17.23 % -583.86 %
Operating 3 Year CFG 37.05 % -19.52 % -6.62 % -2903.43 %
Operating 5 Year CFG 37.05 % -33.04 % -6.62 % -2903.43 %
Operating 10 Year CFG 37.05 % -27.55 % -6.62 % -2903.43 %
EPS Growth -3.49 % -983.33 % -7.75 % -148.15 %
EPS Diluted Growth -3.49 % -983.33 % -7.75 % -148.15 %
Book Value Per Share 8.07 % -31.85 % -74.93 % 2723.84 %
Share Holder 3 Year Equity Growth Per Share 359.09 % -32.29 % - 941.63 %
Share Holder 5 Year Equity Growth Per Share 359.09 % -34.43 % - 941.63 %
Share Holder 10 Year Equity Growth Per Share 359.09 % - - 941.63 %
Dividend Per Share Growth - - 24780.58 % -
Dividend 3 Year Growth Per Share - - 22616.4 % -
Dividend 5 Year Growth Per Share - - 22616.4 % -
Dividend 10 Year Growth Per Share - - 22616.4 % -
Debt Growth 71.8 % -6.4 % 115.62 % 23.15 %
Free Cash Flow Growth -57.3 % 39.17 % 27.5 % -565.47 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
BBNX LH NVST CON KDLY NEUE
Gross Profit Margin TTM 54.31 % 27.42 % 54.14 % 27.06 % 48.92 % 22.17 %
Return on Assets TTM -20.4 % 4.15 % -20.57 % 5.73 % -170.59 % -16.04 %
Return on Equity TTM -57.31 % 8.98 % -37.41 % 34.18 % -146.24 % 21.99 %
Return on Capital Employed TTM -16.21 % 7.1 % 2.73 % 12.85 % -207.45 % 48.49 %
Net Income Per EBT TTM 100 % 77.97 % 103.04 % 71.18 % 100 % 134.07 %
EBT Per Ebit TTM 132.32 % 84.98 % -869.32 % 71.02 % 105.35 % 131.22 %
EBIT Per Revenue TTM -76.95 % 8.37 % 5.01 % 16.01 % -168.04 % -9 %
Cash Flow To Debt Ratio TTM -665.3 % 25.06 % 19 % 46.67 % -559.06 % -9554.9 %
Receivables Turnover TTM 6.15 5.79 6.37 7.49 181.47 21.75
Payables Turnover TTM 8.96 13.32 7.02 40.08 - 129.55
Inventory Turnover TTM 1.97 19.59 4.39 - 791.15 -
Fixed Asset Turnover TTM 571.02 % 426.34 % 598.45 % 288.43 % 359.19 % 8168.43 %
Asset Turnover TTM 20.03 % 74.86 % 45.81 % 70.84 % 96.37 % 101.3 %
Operating Cash Flow Per Share TTM -1.51 19.55 1.72 1.91 -0.62 -11.15
Free Cash Flow Per Share TTM -1.55 13.78 1.55 1.41 -0.68 -11.53
Cash Per Share TTM 753.62 % 441.87 % 624.88 % 41.15 % 18.93 % 1693.17 %
Operating Cash Flow Sales Ratio TTM -68.52 % 12.4 % 11.84 % 12.5 % -150.8 % -10.53 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.8 % 70.5 % 90.32 % 74.01 % 110.48 % 103.45 %
Cash Flow Coverage Ratios TTM -665.3 % 25.06 % 19 % 46.67 % -559.06 % -9554.9 %
Price To Free Cash Flows Ratio TTM -11.52 18.82 12.9 14.26 -17.66 -0.62
Price To Operating Cash Flows Ratio TTM -8.39 13.25 11.86 10.42 -19.52 -0.62
Price Cash Flow Ratio TTM -8.39 13.25 11.86 10.42 -19.52 -0.62
Income Statement (TTM)
BBNX LH NVST CON KDLY NEUE
Revenue $0.07B $13.01B $2.51B $1.9B $0B $0.94B
Gross Profit $0.04B $3.5B $1.37B $0.53B $0B $0.19B
Gross Profit Ratio 55.11% 26.92% 54.68% 27.79% 96.96% 20.77%
EBITDA $-0.04B $1.81B $-0.88B $0.37B $-0B $-0.08B
Net Income $-0.05B $0.75B $-1.12B $0.17B $-0B $-0.13B
EPS Diluted -8.6 8.84 -6.5 1.31 -0.67 -22.65
Balance Sheet (MRQ)
BBNX LH NVST CON KDLY NEUE
Long Term Debt $0.01B $6.08B $1.28B $1.87B $0B $0.2B
Total Liabilities $0.07B $10.31B $2.42B $2.22B $0B $0.93B
Total Equity $0.08B $8.07B $2.93B $0.3B $0B $-0.39B
Total Investments $0.07B $0.02B $0B $0B $0B $0.01B
Total Debt $0.01B $7.27B $1.55B $1.95B $0B $0.2B
Total Assets $0.15B $18.38B $5.35B $2.52B $0B $0.54B
Cash Flow Statement (TTM)
BBNX LH NVST CON KDLY NEUE
Net Income $-0.05B $0.75B $-1.12B $0.17B $-0B $-0.1B
Inventory $-0.01B $-0.01B $0B $0B $0B $0B
Dividends Paid $0B $-0.24B $0B $-1.54B $0B $0B
Operating Cash Flow $-0.05B $1.59B $0.34B $0.27B $-0B $-0.12B
Capital Expenditure $-0B $-0.49B $-0.03B $-0.06B $-0B $-0B
Related Stocks
Ticker Name Price
CON Concentra Group Holdings Parent, Inc. 19.9
KDLY Kindly MD, Inc. Common Stock 12.23
LH Laboratory Corporation of America Holdings 249.62
NEUE NeueHealth, Inc. 6.83
NVST Envista Holdings Corporation 20.2
ETFs With Exposure to BBNX
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.0067 221.7
VTI Vanguard Total Stock Market Index Fund 0 307.02
SCHB Schwab U.S. Broad Market ETF 0.000310879 24.07
SCHA Schwab U.S. Small-Cap ETF 0.00428108 25.93
IWN iShares Russell 2000 Value ETF 0.00167 164.96
IWV iShares Russell 3000 ETF 0.00029 354.59
IWO iShares Russell 2000 Growth ETF 0.01145 288.65
VXF Vanguard Extended Market Index Fund 0.00301 195.91
HDG ProShares Hedge Replication ETF 0.000875312 49.95
UWM ProShares Ultra Russell2000 0.00512778 39.68
URTY ProShares UltraPro Russell2000 0.00411272 42.39
VTWV Vanguard Russell 2000 Value Index Fund 0.00657 145.415
OMFS Invesco Russell 2000 Dynamic Multifactor ETF 0.012 40.76
VTWG Vanguard Russell 2000 Growth Index Fund 0.01175 210.86
VTWO Vanguard Russell 2000 Index Fund 0.00917 89.59
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0.01 42.41
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.0004 104.43
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 104.41
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 49.99
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 49.98
VBINX Vanguard Balanced Index Fund Investor Shares 0 49.99
GINN Goldman Sachs Innovate Equity ETF 0.05 67.455
VTSAX Vanguard Total Stock Market Index Fund 0 149.48
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00301 148.65
VITSX Vanguard Total Stock Market Index Fund 0 149.5
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00301 148.66
VEMPX Vanguard Extended Market Index InstlPlus 0.00301 366.83
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 280.44
RSSL Global X Funds 0.01 87.09
Unlock